| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Supernus Pharmaceuticals, Inc. (SUPN) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. SUPN is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 119.6K | $5.35M | - | |
| Dir | 61.3K | $2.74M | - | |
| Dir | 38.2K | $1.71M | - | |
| VP | 15.5K | $692.8K | - | |
| VP | 14.5K | $648.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 5, 2018 | Vaughn Victor | Sr. VP Of Sales And Marketing | Sale+OE | 60,000 | $45.33 | $2,719,770.00 | -68.2% | |
| Jan 22, 2018 | Bhatt Padmanabh P.69 | Sr. VP Of Ip, CSO | Sale+OE | 20,000 | $48.04 | $960,716.00 | -61.5% | |
| Jan 17, 2018 | Vaughn Victor | Sr. VP Of Sales | Sale+OE | 24,250 | $46.26 | $1,121,749.50 | -56.5% | |
| Jan 17, 2018 | Bhatt Padmanabh P.69 | Sr. VP Of Ip, CSO | Sale+OE | 20,000 | $44.98 | $899,500.00 | -61.5% | |
| Jan 12, 2018 | Vaughn Victor | Sr. VP Of Sales | Sale+OE | 5,750 | $45.03 | $258,927.68 | -38.1% | |
| Jan 11, 2018 | Patrick Gregory S | VP, Chief Financial Officer | Sale+OE | 50,000 | $43.56 | $2,178,145.00 | -47.2% | |
| Jan 9, 2018 | Vaughn Victor | Sr. VP Of Sales | Sale+OE | 15,000 | $42.04 | $630,649.50 | -61.6% | |
| Jan 2, 2018 | Vaughn Victor | Sr. VP Of Sales | Sale+OE | 55,000 | $40.11 | $2,206,308.50 | -85.5% | |
| Sep 8, 2017 | Bhatt Padmanabh P.69 | Sr VP Of Ip, CSO | Sell | 5,000 | $49.86 | $249,302.50 | -28.6% | |
| Sep 8, 2017 | Patrick Gregory S | VP, Chief Financial Officer | Sale+OE | 50,000 | $47.60 | $2,379,779.46 | -72.8% |